Top

Current Treatment Options in Gastroenterology

Content (8 Articles)

Infliximab: Use in inflammatory bowel disease

Win J. Travassos, Adam S. Cheifetz

Management of perianal Crohn’s disease

Benjamin Person, Steven D. Wexner

Managing functional disturbances in patients with inflammatory bowel disease

Philip M. Ginsburg, Theodore M. Bayless

The role of antibiotics in inflammatory bowel disease

Chandrashekhar Thukral, Win J. Travassos, Mark A. Peppercorn

Management of malignant colonic obstruction

Douglas G. Adler

Chemotherapy of metastatic colorectal cancer

Everardo D. Saad, Paulo M. Hoff

Treatment of gastrointestinal acute graft-versus-host disease

William A. Ross

Chronic diarrhea

Lawrence R. Schiller

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.